Continuous and non-continuous flow bioreactor

• US 20050064465A1
• Filed: 07/02/2004
• Published: 03/24/2005
• Est. Priority Date: 07/02/2003
• Status: Abandoned Application

• Current Assignee: Caliper Life Sciences Incorporated (Revvity, Inc.)
• Original Assignee: Caliper Life Sciences Incorporated (Revvity, Inc.)
• Inventors: Kirby, Celeste, Rosoff, Monica, Gentalen, Erik, Dettloff, Roger
• Application Number:
  US10/884,170
• Publication Number:
  US 20050064465A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: B01L 2400/0415 electrical forces, e.g. electrokinetic
• CPC Class Codes: B01L 2400/049 vacuum
• CPC Class Codes: B01L 3/5027 by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip B01L3/5023 takes precedence; micromixers B01F33/30; microreactors for synthesis B01J19/0093; microcapillary devices in general B81B1/00
• CPC Class Codes: B01L 7/52 with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples amplification or hybridisation processes per se C12Q1/68; controlling sequential reactions for synthesis B01J19/0046
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/6865 Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
• CPC Class Codes: C12Q 2565/629 being a microfluidic device

Abstract

Methods and systems for performing continuous amplification of RNA and other nucleic acids are provided. Expression profiling using the continuous flow RNA amplification systems are also provided.

Claims

1. A method of amplifying at least one RNA, the method comprising:

flowing one or more RNA amplification reagent into a microscale chamber; and

, amplifying one or more template nucleic acid to produce one or more RNA amplicon in the microscale reaction chamber under conditions of constant or semi-constant flow, wherein one or more reaction parameter is optimized to provide production of the RNA amplicons in the reaction chamber, or flow of the amplicons out of the chamber, or both.

2. The method of claim 1, wherein the one or more RNA amplification reagents comprise one or more of:

a solid support, the template nucleic acid, a DNA template, a poly(dT) oligonucleotide with an RNA polymerase promoter sequence, a cell, a cell extract, a reverse transcriptase, an rNTP, a dNTP, Mg++, or a buffer.

3. The method of claim 1, wherein amplifying the nucleic acid comprises expressing a DNA that encodes the RNA amplicon, in vitro.

4. The method of claim 1, wherein amplifying the one or more nucleic acids comprises expressing a plurality of cDNAs that encode total polyA mRNA from a biological sample.

5. The method of claim 4, wherein the biological sample comprises fewer than about 10 cells.

6. The method of claim 4, wherein the biological sample comprises about 1 cell.

7. The method of claim 4, wherein the biological sample comprises more than about 100 cells.

8. The method of claim 4, wherein the biological sample comprises more than about 1,000 cells.

9. The method of claim 1, wherein the reaction parameter is selected from the group consisting of:

a rate of flow in the chamber, a temperature in the chamber, a concentration of one or more of the RNA amplification reagents in the chamber, inhibiting or enhancing DNA transcription in the amplification chamber, a channel size leading into or out of the chamber, a size of the chamber, a bead diameter of a bead bound to one or more additional RNA amplification reagent, total porosity of a bead bed bound to one or more additional RNA amplification reagent, a percent of fluid that diffuses in and out of a bead bed bound to one or more additional RNA amplification reagent as the fluid flows through and along the bead bed, residence time of reaction substrates or products through a bead bed, distance traveled by reaction substrates or products through a bead bed, and a direction of flow of one or more reactants or products through a bead bed.

10. The method of claim 1, wherein one or more additional RNA amplification reagent is contained within a bead bed that fills a deep portion of a microscale channel, wherein the channel comprises a lateral step up in depth, wherein the one or more amplification reagents and amplicons flow along a side of the bead bed and diffuse laterally in and out of the bead bed.

11. The method of claim 1, further comprising detecting the RNA amplicon.

12. The method of claim 11, wherein detecting the RNA amplicon comprises flowing the RNA amplicon into contact with an oligonucleotide array.

13. The method of claim 12, wherein the RNA amplicon is flowed out of the reaction chamber into contact with the array under constant flow conditions.

14. The method of claim 13, wherein the array is in one or more microchamber.

15. The method of claim 11, wherein detecting the RNA amplicon comprises real time detection or quantification of RNA amplicon formation.

16. The method of claim 11, wherein detecting the RNA amplicons comprises flowing an aliquot of a labeled amplicon past a fluorescence detector and determining a yield of the amplifying step.

17. The method of claim 11, wherein detecting the RNA amplicon comprises electrophoresing the amplicon through a matrix and detecting at least one resulting size separated RNA amplicon.

18. The method of claim 11, wherein detection of the RNA amplicon is a diagnostic or prognostic indicator for one or more polymorphism, SNP, disease or condition.

19. The method of claim 1, further comprising translating the RNA amplicons into one or more translation products.

20. The method of claim 19, wherein the translation products are detected or quantified in real time.

21. method of claim 19, wherein the translation products are detected by binding an antibody to the product and detecting binding of the antibody to the translation product.

22. The method of claim 19, wherein an in vitro translation reagent is contacted to the RNA amplicons under conditions of continuous or semi-continuous flow.

23. The method of claim 1, wherein amplifying the template nucleic acid comprises performing a Van Gelder-Eberwine series of reactions that converts one or more starting RNA into DNA by reverse transcription, performs a second strand synthesis to produce double stranded DNA and transcribes the double stranded DNA to produce the RNA amplicons.

24. The method of claim 1, wherein the amplifying step is performed twice in series, with the RNA amplicon from a first amplification reaction being used as the template nucleic acid for a second amplifying step.

25. The method of claim 24, wherein the second amplifying step comprises a Van-Gelder Eberwine reaction.

26. The method of claim 1, further comprising cleaving the RNA amplicon.

27. A method of detecting presence or absence of one or more target RNA in a biological sample, the method comprising:

performing one of more reverse transcription reaction on sample RNA from the biological sample to produce one or more cDNA;

flowing transcription reagents into contact with the one or more cDNA;

performing one or more expression reaction on the cDNA under conditions of continuous or semi-continuous flow; and

,

detecting one or more RNA amplicon, or lack thereof, produced by the expression reaction, thereby detecting presence or absence of the target RNA.